Most carriers of heterozygous DPYD mutations are healthy, but some patients with hemizygous deletions affecting DPYD have neurodevelopmental disorders, including autism spectrum disorders [43–45], schizophrenia [46], epilepsy [47], and intellectual disability [42, 48, 49]. The gene discussed is DPYD; the disease is epilepsy.